How can we build resilience into the frontlines of health systems?
How can health systems be more resilient to the impacts of infectious diseases such as Ebola, SARS, HINI, and Covid-19? Experts discuss the role of frontline workers and …
Blog
Our blog highlights evidence-based opinions, drawing on our collective experience across countries and sectors to spark discussion and encourage debate. You can search our blog, refining by area of expertise, team, country, or keywords.
19 – 27 of 407
Podcast: How has Covid-19 affected children and teachers in non-state schools in Pakistan?
The second episode in our series exploring the impact of the Covid-19 pandemic on non-state schools around the world.
What does it take to be a successful third party monitor?
How to increase the speed and usefulness of programme evaluations – we look at the ‘dos’ and don’ts’ of third party monitors.
Preserving liquidity in Ghana’s susu collection system during the Covid–19 crisis
How informal savings clubs in Ghana adapted to meet customer demands during the Covid-19 pandemic, and are now stronger than ever.
Women in India: why collective action matters now more than ever
Women's groups in India have the power to redress inequality and bring about lasting change, but how has Covid-19 impacted the gains made to women's empowerment?
After the pandemic…doing development better
Our CEO, Mark Henstridge reflects on why, in a post-pandemic world how aid gets spent and secures impact is often more important than how much we spend – for developing …
Dasgupta Review: Putting a value on biodiversity – but are long-term aims being missed in the heat of the Covid crisis?
Nature in the time of Covid - our Chief Economist, Stevan Lee, looks at the likely impact of the pioneering Dasgupta Review
Remote qualitative data collection: Lessons from a multi-country qualitative evaluation
Following an endline evaluation of an education programme we share eight factors that can help make remote data collection during Covid-19 a success
Meet the challenges: Rolling out Covid-19 vaccination in low-and middle-income countries
What are the barriers to global Covid-19 vaccine distribution and how can countries potentially minimise these issues?